Multi-Target Approach of Murraya koenigii Leaves in Treating Neurodegenerative Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tan, Mario A. | - |
dc.contributor.author | Sharma, Niti | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.date.accessioned | 2022-03-28T04:40:12Z | - |
dc.date.available | 2022-03-28T04:40:12Z | - |
dc.date.created | 2022-02-07 | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83842 | - |
dc.description.abstract | Neurodegenerative diseases (NDs) mainly affect neurons and gradually lead to a loss of normal motor and cognitive functions. Atypical protein homeostasis—misfolding, aggregations and accumulations, oxidative stress, inflammation, and apoptosis—are common features in most NDs. To date, due to the complex etiology and pathogenesis of NDs, no defined treatment is available. There has been increasing interest in plant extracts as potential alternative medicines as the presence of various active components may exert synergistic and multi-pharmacological effects. Murraya koenigii (Rutaceae) is utilized in Ayurvedic medicine for various ailments. Pharmacological studies evidenced its potential antioxidant, anti-inflammatory, anticancer, hepatoprotective, immunomodulatory, antimicrobial, and neuroprotective activities, among others. In line with our interest in exploring natural agents for the treatment of neurodegenerative diseases, this review presents an overview of literature concerning the mechanisms of action and the safety profile of significant bioactive components present in M. koenigii leaves to support further investigations into their neuroprotective therapeutic potential. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | Pharmaceuticals | - |
dc.title | Multi-Target Approach of Murraya koenigii Leaves in Treating Neurodegenerative Diseases | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000769419900001 | - |
dc.identifier.doi | 10.3390/ph15020188 | - |
dc.identifier.bibliographicCitation | Pharmaceuticals, v.15, no.2 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85123891225 | - |
dc.citation.title | Pharmaceuticals | - |
dc.citation.volume | 15 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Sharma, Niti | - |
dc.contributor.affiliatedAuthor | An, Seong Soo A. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Carbazole alkaloids | - |
dc.subject.keywordAuthor | Essential oils | - |
dc.subject.keywordAuthor | Murraya koenigii | - |
dc.subject.keywordAuthor | Natural products | - |
dc.subject.keywordAuthor | Neurodegenerative disease | - |
dc.subject.keywordAuthor | Toxicity | - |
dc.subject.keywordPlus | CANNABINOID CB2 RECEPTORS | - |
dc.subject.keywordPlus | TOTAL ALKALOIDAL EXTRACT | - |
dc.subject.keywordPlus | IN-VITRO ANTIOXIDANT | - |
dc.subject.keywordPlus | ACID AMIDE HYDROLASE | - |
dc.subject.keywordPlus | LEAF ESSENTIAL OILS | - |
dc.subject.keywordPlus | CARBAZOLE ALKALOIDS | - |
dc.subject.keywordPlus | BETA-CARYOPHYLLENE | - |
dc.subject.keywordPlus | INDUCED NEUROTOXICITY | - |
dc.subject.keywordPlus | CHEMICAL-COMPOSITION | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.